International Journal of Medical Toxicology and Forensic Medicine

[1] Mahmud H, Landskroner E, Amza A, Aragie S, Godwin WW, de Hostos Barth A, et al. Stopping azithromycin mass drug administration for trachoma: A systematic review. PLoS Negl Trop Dis. 2021;15(7):e0009491. [DOI: 10.1371/journal.pntd.0009491]

[2] Dongmo OLM, Epoh NJ, Tadjoua HT, Yousuf S, Telefo PB, Tapondjou LA, et al. Acute and sub-acute toxicity of the aqueous extract from the stem bark of Tetrapleura tetrapteura Taub. (Fabaceae) in mice and rats. J Ethnopharmacol. 2019;236:42–9. [DOI: 10.1016/j.jep.2019.02.026]

[3] Chen L, Qin F, Ma Y, Li F. Quantitative determination of Azithromycin in human plasma by ultra performance liquid chromatography-electrospray ionization mass spectrometry and its application in a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;855(2):255–61. [DOI: 10.1016/j.jchromb.2007.05.016]

[4] Sharma K, Mullangi R. A concise review of HPLC, LC-MS and LC-MS/MS methods for determination of Azithromycin in various biological matrices. Biomed Chromatogr. 2013;27(10):1243–58. [DOI: 10.1002/bmc.2898]

[5] Zhang Y, Bala V, Chhonker YS, Aldhafiri WN, John LN, Bjerum CM, et al. A simple, high-throughput and validated LC-MS/MS method for the determination of Azithromycin in human plasma and its application to a clinical pharmacokinetic study. Biomed Chromatogr. 2022;36(10):e5443. [DOI: 10.1002/bmc.5443]

[6] Westphal JF. Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, Azithromycin and dirithromycin. Br J Clin Pharmacol. 2000;50(4):285–95. [DOI: 10.1046/j.1365-2125.2000.00261.x]

[7] Woodhead JL, Yang K, Oldach D, MacLauchlin C, Fernandes P, Watkins PB, et al. Analyzing the Mechanisms Behind Macrolide Antibiotic-Induced Liver Injury Using Quantitative Systems Toxicology Modeling. Pharm Res. 2019;36(3):48. [DOI: 10.1007/s11095-019-2582-y]

[8] Villanueva-Paz M, Morán L, López-Alcántara N, Freixo C, Andrade RJ, Lucena MI, et al. Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice. Antioxidants (Basel, Switzerland). 2021;10(3). [DOI: 10.3390/antiox10030390]

[9] Shinkai M, Henke MO, Rubin BK. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action. Pharmacol Ther. 2008;117(3):393–405. [DOI: 10.1016/j.pharmthera.2007.11.001]

[10] Martinez MA, Vuppalanchi R, Fontana RJ, Stolz A, Kleiner DE, Hayashi PH, et al. Clinical and histologic features of azithromycin-induced liver injury. Clin Gastroenterol Hepatol. 2015;13(2):369-376.e3. [DOI: 10.1016/j.cgh.2014.07.054]

[11] Wu H, Bao X, Gutierrez AH, Nevzorova YA, Cubero FJ. Role of oxidative stress and endoplasmic reticulum stress in drug-induced liver injury. Explor Dig Dis. 2023;2(3):83–99. [DOI: 10.37349/edd.2023.00020]

[12] Liu P, Zhang Y, Zhang Z, Huang X, Su X, Yang S, et al. Antibiotic-Induced Dysbiosis of the Gut Microbiota Impairs Gene Expression in Gut-Liver Axis of Mice. Genes (Basel). 2023;14(7). [DOI:10.3390/genes14071423]

[13] He M, Shi J, Liu A, Xu YJ, Liu Y. Antibiotic-induced gut microbiota dysbiosis altered host metabolism. Mol Omi. 2023;19(4):330–9. [DOI: 10.1039/d2mo00284a]

[14] Dahiya D, Nigam PS. Antibiotic-Therapy-Induced Gut Dysbiosis Affecting Gut Microbiota-Brain Axis and Cognition: Restoration by Intake of Probiotics and Synbiotics. Int J Mol Sci. 2023;24(4). [DOI: 10.3390/ijms24043074]

[15] Gao W, Guo L, Yang Y, Wang Y, Xia S, Gong H, et al. Dissecting the Crosstalk Between Nrf2 and NF-κB Response Pathways in Drug-Induced Toxicity. Front Cell Dev Biol. 2022;Volume 9. [Link]

[16] Chunmei Z, Shuai W. Molecular mechanisms of neuroprotective effect of Rutin. Front Pharmacol. 2025;Volume 16. [Link]

[17] Emeka PM, Badger-Emeka LI, Thirugnanasambantham K, Alatawi AS. Rutin-Activated Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Attenuates Corneal and Heart Damage in Mice. Pharmaceuticals (Basel). 2024;17(11). [DOI: 10.3390/ph17111523]

[18] Rahmani S, Naraki K, Roohbakhsh A, Hayes AW, Karimi G. The protective effects of Rutin on the liver, kidneys, and heart by counteracting organ toxicity caused by synthetic and natural compounds. Food Sci Nutr. 2023;11(1):39–56. [DOI: 10.1002/fsn3.3041]

[19] Mahmoud AM, Ahmed RR, Soliman HA, Salah M. Ruta graveolens and its active constituent rutin protect against diethylnitrosamine-induced nephrotoxicity through modulation of oxidative stress. J Appl Pharm Sci. 2015;5(10):16–21. [DOI: 10.7324/JAPS.2015.50104]

[20] Bancroft JD, Gamble M. Theory and practice of histological techniques. Elsevier health sciences; 2008. [Link]

[21] Usadadia S V, Patel JM, Vihol PD, Urkude AP. Protective effect of quercetin on Azithromycin induced hepatotoxicity and nephrotoxicityin Wistar rats. Int J Curr Microbiol App Sci. 2020;9(9):2926–34. [DOI: 10.20546/ijcmas.2020.909.360]

[22] Martínez-Trejo A, Ruiz-Ruiz JM, Gonzalez-Avila LU, Saldaña-Padilla A, Hernández-Cortez C, Loyola-Cruz MA, et al. Evasion of antimicrobial activity in acinetobacter baumannii by target site modifications: an effective resistance mechanism. Int J Mol Sci. 2022;23(12):6582. [DOI: 10.3390/ijms23126582]

[23] Abushaheen MA, Muzaheed, Fatani AJ, Alosaimi M, Mansy W, George M, et al. Antimicrobial resistance, mechanisms and its clinical significance. Dis Mon. 2020;66(6):100971. [DOI: 10.1016/j.disamonth.2020.100971]

[24] Altenburg J, de Graaff CS, van der Werf TS, Boersma WG. Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms. Respiration. 2011;81(1):67–74. [DOI: 10.1159/000320319]

[25] Zarogoulidis P, Papanas N, Kioumis I, Chatzaki E, Maltezos E, Zarogoulidis K. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. Eur J Clin Pharmacol. 2012;68(5):479–503. [DOI: 10.1007/s00228-011-1161-x]

[26] Choi SS, Park HR, Lee KA. A Comparative Study of Rutin and Rutin Glycoside: Antioxidant Activity, Anti-Inflammatory Effect, Effect on Platelet Aggregation and Blood Coagulation. Antioxidants (Basel, Switzerland). 2021;10(11). [DOI: 10.3390/antiox10111696]

[27] Satari A, Ghasemi S, Habtemariam S, Asgharian S, Lorigooini Z. Rutin: A Flavonoid as an Effective Sensitizer for Anticancer Therapy; Insights into Multifaceted Mechanisms and Applicability for Combination Therapy. Evid Based Complement Alternat Med. 2021;2021:9913179. [DOI: 10.1155/2021/9913179]

[28] Lee OYA, Wong ANN, Ho CY, Tse KW, Chan AZ, Leung GPH, et al. Potentials of Natural Antioxidants in Reducing Inflammation and Oxidative Stress in Chronic Kidney Disease. Antioxidants (Basel, Switzerland). 2024;13(6). [DOI: 10.3390/antiox13060751]

[29] Liu Q, Pan R, Ding L, Zhang F, Hu L, Ding B, et al. Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries. Int Immunopharmacol. 2017;49:132–41. [DOI: 10.1016/j.intimp.2017.05.026]

[30] Farha AK, Gan RY, Li HB, Wu DT, Atanasov AG, Gul K, et al. The anticancer potential of the dietary polyphenol rutin: Current status, challenges, and perspectives. Crit Rev Food Sci Nutr. 2022;62(3):832–59. [DOI: 10.1080/10408398.2020.1829541]

[31] Molaei E, Molaei A, Abedi F, Hayes AW, Karimi G. Nephroprotective activity of natural products against chemical toxicants: The role of Nrf2/ARE signaling pathway. Food Sci Nutr. 2021;9(6):3362–84. [DOI: 10.1002/fsn3.2320]

[32] Ranasinghe R, Mathai M, Zulli A. Cytoprotective remedies for ameliorating nephrotoxicity induced by renal oxidative stress. Life Sci. 2023;318:121466. [DOI: 10.1016/j.lfs.2023.121466]

[33] Diwan V, Brown L, Gobe GC. The flavonoid rutin improves kidney and heart structure and function in an adenine-induced rat model of chronic kidney disease. J Funct Foods. 2017;33:85–93. [Link]

[34] Pandey P, Khan F, Qari HA, Oves M. Rutin (Bioflavonoid) as Cell Signaling Pathway Modulator: Prospects in Treatment and Chemoprevention. Pharmaceuticals (Basel). 2021;14(11). [DOI: 10.3390/ph14111069]

[35] Han Y, Lu JS, Xu Y, Zhang L, Hong BF. Rutin ameliorates renal fibrosis and proteinuria in 5/6-nephrectomized rats by anti-oxidation and inhibiting activation of TGFβ1-smad signaling. Int J Clin Exp Pathol. 2015;8(5):4725–34. [Link]

[36] Rysz J, Franczyk B, Ławiński J, Olszewski R, Ciałkowska-Rysz A, Gluba-Brzózka A. The Impact of CKD on Uremic Toxins and Gut Microbiota. Toxins (Basel). 2021;13(4). [DOI: 10.3390/toxins13040252]

[37] Shah T, Baloch Z, Shah Z, Cui X, Xia X. The Intestinal Microbiota: Impacts of Antibiotics Therapy, Colonization Resistance, and Diseases. Int J Mol Sci. 2021;22(12). [DOI: 10.3390/ijms22126597]

[38] Wang G, Gong H, Zou Y, Zhang H, Mao X. Bifidobacterium animalis Subsp. lactis PB200 Improves Intestinal Barrier Function and Flora Disturbance in Mice with Antibiotic-Induced Intestinal Injury. Nutrients [Internet]. 2025 ;17(10). [DOI: 10.3390/nu17101610]

[39] Hanafy SM, Zakaria SS. The Protective Role of Folic Acid in Biochemical and Histopathological Changes Induced by Azithromycin in the Livers of Pregnant Albino Rats. Medicina (Kaunas). 2025 ;61(3). [DOI: 10.3390/medicina61030415]

[40] Sakurai T, Kamio K, Sasaki K, Nishimoto T, Yamaguchi J ichi, Sasaki M, et al. Imaging Mass Microscopy of Kidneys from Azithromycin-Treated Rats with Phospholipidosis. Am J Pathol [Internet]. 2018;188(9):1993–2003. [Link]

[41] Ali MAM, Matouk AI, Hamza AA, Amin A, Heeba GH. Gallic and glycyrrhetinic acids prevent azithromycin-induced liver damage in rats by mitigating oxidative stress and inflammation. Sci Rep. 2025;15(1):9566. [DOI: 10.1038/s41598-025-93120-3]

[42] Mohsen AM, Wagdi MA, Salama A. Rutin loaded bilosomes for enhancing the oral activity and nephroprotective effects of Rutin in potassium dichromate induced acute nephrotoxicity in rats. Sci Rep. 2024 ;14(1):23799. [DOI: 10.1038/s41598-024-73567-6]

[43] Prasad R, Prasad SB. Histoprotective effect of Rutin against cisplatin-induced toxicities in tumor-bearing mice: Rutin lessens cisplatin-induced toxicities. Hum Exp Toxicol. 2020 ;40(2):245–58. [DOI: 10.1177/0960327120947793]

[44] Kwiatkowska E, Domański L, Dziedziejko V, Kajdy A, Stefańska K, Kwiatkowski S. The Mechanism of Drug Nephrotoxicity and the Methods for Preventing Kidney Damage. Int J Mol Sci. 2021;22(11). [DOI:10.3390/ijms22116109]